SG Americas Securities
TIL icon

SG Americas Securities’s Instil Bio TIL Stock Holding History

SG Americas Securities’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,395
Closed -$18K – 3141
2023
Q1 		$18K Buy
1,395
+118
+9% +$1.74K ﹤0.01% 3164
2022
Q4 		$16K Buy
1,277
+118
+10% +$5.83K ﹤0.01% 2953
2022
Q3 		$112K Sell
1,159
-186
-14% -$21.3K ﹤0.01% 2787
2022
Q2 		$124K Buy
+1,345
New +$190K ﹤0.01% 2981
2022
Q1 		– Sell
-444
Closed -$152K – 3426
2021
Q4 		$152K Buy
+444
New +$171K ﹤0.01% 2822

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SG Americas Securities's TIL Position: Q2 2023 in Review

SG Americas Securities sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 1,395 shares — an estimated $18K sold.

SG Americas Securities first reported a position in TIL in Q4 2021 and held it in 5 quarters. The position peaked at $152K in Q4 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • SG Americas Securities reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 1,395 Instil Bio shares in Q2 2023, an estimated $18K.
  • SG Americas Securities first reported a position in Instil Bio in Q4 2021 and held it in 5 quarters.
  • SG Americas Securities's Instil Bio position peaked at $152K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.